Polyclonal Rabbit anti‑Human NAG20 / UBAP1 Antibody (aa6‑33, WB) LS‑C328987
Polyclonal Rabbit anti‑Human NAG20 / UBAP1 Antibody (aa6‑33, WB) LS‑C328987
Antibody:
NAG20 / UBAP1 Rabbit anti-Human Polyclonal (aa6-33) Antibody
Format:
Unconjugated, Unmodified
Overview
Antibody:
NAG20 / UBAP1 Rabbit anti-Human Polyclonal (aa6-33) Antibody
Format:
Unconjugated, Unmodified
Specifications
Description
UBAP1 antibody LS-C328987 is an unconjugated rabbit polyclonal antibody to UBAP1 (NAG20) (aa6-33) from human. It is reactive with human and mouse. Validated for ELISA and WB.
Target
Human NAG20 / UBAP1
Synonyms
UBAP1 | UAP | UBAP-1 | Ubiquitin-associated protein 1 | Ubiquitin associated protein | NAG20 | UBAP | Ubiquitin associated protein 1
Reactivity
Human, Mouse
(tested or 100% immunogen sequence identity)
Conjugations
Unconjugated.
Also available conjugated with
APC,
Biotin,
FITC,
HRP,
PE.
Purification
Affinity purified
Modifications
Unmodified.
Also available
Azide-free.
Specificity
This UBAP1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 6-33 amino acids from the N-terminal region of human UBAP1.
Applications
- Western blot (1:100 - 1:500)
- ELISA (1:1000)
Presentation
PBS, 0.09% Sodium Azide
Storage
Short term: store at 4°C. Long term: aliquot and store at -20°C for up to 6 months. Avoid freeze-thaw cycles. Protect from light.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
Featured Products
Species:
Human
Applications:
IHC, Immunofluorescence, Western blot, Immunoprecipitation, ELISA
Species:
Human, Mouse
Applications:
IHC, IHC - Paraffin, Western blot, Flow Cytometry
Species:
Human, Mouse, Rat
Applications:
Western blot, ELISA
Source:
E. coli
Tag:
His-T7
Source:
E. coli
Tag:
His-T7
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 4/29/2024